A detailed history of Lpl Financial LLC transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 57,980 shares of RGLS stock, worth $85,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,980
Previous 46,980 23.41%
Holding current value
$85,230
Previous $84,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$1.46 - $1.9 $16,060 - $20,900
11,000 Added 23.41%
57,980 $91,000
Q2 2024

Aug 07, 2024

SELL
$1.79 - $2.8 $119,035 - $186,200
-66,500 Reduced 58.6%
46,980 $84,000
Q1 2024

May 10, 2024

BUY
$1.13 - $2.88 $128,232 - $326,822
113,480 New
113,480 $326,000
Q2 2023

Jul 31, 2023

BUY
$0.87 - $1.75 $4,350 - $8,750
5,000 Added 37.03%
18,502 $27,000
Q1 2023

May 10, 2023

BUY
$0.79 - $1.61 $10,666 - $21,738
13,502 New
13,502 $11,000

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $21.5M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.